Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Weidemann

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
BMC Cardiovascular Disorders|October 30, 2016
Myocardial lipid content in Fabry disease: a combined <sup>1</sup>H-MR spectroscopy and MR imaging study at 3 TeslaB Petritsch, H Köstler, A M Weng, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|August 16, 2012
Non-invasive determination of myocardial lipid content in Fabry disease by 1H-MR spectroscopyB Petritsch, H Köstler, W Machann, et al.
Neurology|May 29, 2003
Idebenone treatment in Friedreich's ataxia: neurological, cardiac, and biochemical monitoringG Buyse, L Mertens, G Di Salvo, et al.
European Journal of Echocardiography : the Journal of the Working Group on Echocardiography of the European Society of Cardiology|May 17, 2003
The feasibility of ultrasonic regional strain and strain rate imaging in quantifying dobutamine stress echocardiographyM Kowalski, M-C Herregods, L Herbots, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|January 19, 2010
T Buck, O-A Breithardt, L Faber, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Methods for Health Economic Evaluations of Vaccines - Results from an International Expert-WorkshopB Ultsch, O Damm, P Beutels, et al.
International Journal of Cardiology|December 3, 2014
Uncertain diagnosis of Fabry disease: consensus recommendation on diagnosis in adults with left ventricular hypertrophy and genetic variants of unknown significanceB E Smid, L van der Tol, F Cecchi, et al.
JIMD Reports|February 23, 2013
Recommendations on reintroduction of agalsidase Beta for patients with fabry disease in europe, following a period of shortageGabor E Linthorst, Alessandro P Burlina, Franco Cecchi, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
BMC Cardiovascular Disorders|October 30, 2016
Myocardial lipid content in Fabry disease: a combined <sup>1</sup>H-MR spectroscopy and MR imaging study at 3 TeslaB Petritsch, H Köstler, A M Weng, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|August 16, 2012
Non-invasive determination of myocardial lipid content in Fabry disease by 1H-MR spectroscopyB Petritsch, H Köstler, W Machann, et al.
Neurology|May 29, 2003
Idebenone treatment in Friedreich's ataxia: neurological, cardiac, and biochemical monitoringG Buyse, L Mertens, G Di Salvo, et al.
European Journal of Echocardiography : the Journal of the Working Group on Echocardiography of the European Society of Cardiology|May 17, 2003
The feasibility of ultrasonic regional strain and strain rate imaging in quantifying dobutamine stress echocardiographyM Kowalski, M-C Herregods, L Herbots, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|January 19, 2010
T Buck, O-A Breithardt, L Faber, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Methods for Health Economic Evaluations of Vaccines - Results from an International Expert-WorkshopB Ultsch, O Damm, P Beutels, et al.
International Journal of Cardiology|December 3, 2014
Uncertain diagnosis of Fabry disease: consensus recommendation on diagnosis in adults with left ventricular hypertrophy and genetic variants of unknown significanceB E Smid, L van der Tol, F Cecchi, et al.
JIMD Reports|February 23, 2013
Recommendations on reintroduction of agalsidase Beta for patients with fabry disease in europe, following a period of shortageGabor E Linthorst, Alessandro P Burlina, Franco Cecchi, et al.
Pageof 5